# Phase I Trial of Measles Vectored Chikungungya Vaccine

> **NCT03028441** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 180 (actual)

## Conditions studied

- Chikungunya Virus Infection

## Interventions

- **OTHER:** Placebo
- **BIOLOGICAL:** VRC-CHKVLP059-00-VP

## Key facts

- **NCT ID:** NCT03028441
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-30
- **Primary completion:** 2019-01-17
- **Final completion:** 2019-01-17
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2020-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028441, "Phase I Trial of Measles Vectored Chikungungya Vaccine". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03028441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*